
News|Articles|July 1, 2003
Pharmaceutical marketing practices and generic drugs in the spotlight
Author(s)Jill Wechsler
Formulary committees, pharmacy benefit managers (PBMs), pharmacists, and physicians face increased scrutiny of their relationships with pharmaceutical manufacturers under a final fraud policy statement from the Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS).
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
3
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
4
Intervention boosts connected insulin pen adoption among minorities with Type 1 diabetes
5


























